It was shown that in HR-deficient cancers, including BRCA1- or BRCA2-deficient cancers, the inhibition of PARP1 could lead to the accumulation of unrepaired SSBs and their conversion into DSBs through replication fork collision [141]. Here, PARP1 is linked to cancer.